Workflow
糖尿病防控
icon
Search documents
中国糖尿病流行趋势深度解析:2050年患病率或突破30%大关
GLP1减重宝典· 2025-08-10 09:29
以下文章来源于内分泌早知道 ,作者关注内分泌的 内分泌早知道 . 深度分享内分泌用药经验、病例剖析、指南专业解读并紧跟国内外内分泌领域前沿进展,「每医健」旗下内容平台。 ▍中国糖尿病危机:18年患者激增163%,未来防控形势严峻 最新研究数据显示,中国糖尿病流行趋势已进入加速期,患病人数呈现爆炸式增长。截至2023年, 我国糖尿病患者总数已攀升至2.33 亿人 (9 5%置信区间:2. 15亿~2 .52亿),患病率高达15.8 8%。这一数字与2005年的8848万患者相比, 短短1 8年间增幅达16 3% , 相当于平均每年增加约800万新发病例,疾病负担之重远超预期。 从年龄标准化患病率(ASR)来看,增长趋势同样触目惊心。2 005年,我国糖尿病ASR仅为7.53%,而到2023年已飙升至13. 67%, 年均增长率高达3.36% 。这意味着,即使排除人口老龄化因素,糖尿病在普通人群中的蔓延速度仍然惊人。更令人担忧的是,糖尿病 带来的健康损失也在急剧上升。2023年,全国因糖尿病导致的伤残调整寿命年(YLDs)达到3249万,相比2005年的数据, YLDs的 年龄标准化率年均增长4.68% ,表明该 ...
全球糖尿病危机加剧:中国未确诊患者达7300万,健康警报亟待关注
GLP1减重宝典· 2025-07-30 06:09
Core Viewpoint - The article highlights the alarming rise in global diabetes prevalence, with over 800 million adults affected, and emphasizes the urgent need for improved public health strategies and early intervention, particularly in high-risk populations like China [5][9][10]. Group 1: Global Diabetes Trends - The total number of global adult diabetes patients has surpassed 800 million, a fourfold increase since 1990, with 4.45 million untreated patients aged 30 and above in 2022 [5][9]. - By 2050, global diabetes patients are projected to exceed 1.31 billion, indicating a significant public health challenge ahead [7]. - The global diabetes prevalence rate increased by 90.5% from 1990 to 2021, rising from 3.2% to 6.1% [7]. Group 2: Diabetes in China - China has 148 million diabetes patients, ranking second globally, with over 52% of these patients untreated [9][10]. - The majority of new diabetes cases in China are type 2 diabetes, accounting for 99.2% of new cases in 2021 [10]. - The gender disparity in diabetes-related health burdens is notable, with men experiencing a higher disability burden compared to women [10]. Group 3: Complications and Healthcare Burden - Approximately 30% to 40% of diabetes patients may develop chronic kidney disease (CKD), with type 2 diabetes being a major contributing factor [8]. - The number of new CKD cases due to type 2 diabetes rose from 1.4 million in 1990 to 2.4 million in 2017, a 74% increase [8]. - The treatment resources for end-stage kidney disease (ESKD) are unevenly distributed globally, with only 27% to 53% of patients receiving necessary care [8]. Group 4: Prevention and Control Strategies - The updated "China Diabetes Prevention and Control Guidelines (2024)" indicates a continuous rise in diabetes prevalence, necessitating enhanced screening and diagnostic measures [11][12]. - The national health initiative aims to increase diabetes awareness and screening rates, targeting a 60% awareness rate among adults by 2030 [12][13]. - The guidelines emphasize the importance of regular blood sugar testing for high-risk groups and the need for improved healthcare capabilities at the grassroots level [12][13].